|1.||Gürer, Cansel Köse: 1 article (03/2007)|
|2.||Sahin, Sedef: 1 article (03/2007)|
|3.||Aşan, Esin: 1 article (03/2007)|
|4.||Kölemen, Fikret: 1 article (03/2007)|
|5.||Uğur, Yeşim: 1 article (03/2007)|
|6.||Korkusuz, Petek: 1 article (03/2007)|
|7.||Erkin, Gul: 1 article (03/2007)|
|8.||Zheng, Run: 1 article (06/2006)|
|9.||Scattergood, Joseph: 1 article (06/2006)|
|10.||Marshall, K Wayne: 1 article (06/2006)|
|1.||Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
11/01/1987 - "Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis."
11/01/1987 - "The presence of activated T cells as judged from the reaction with monoclonal antibodies (MoAb) against (a) a late stage T cell activation antigen (VLA-1), (b) the interleukin 2 (IL2) receptor (CD25), and (c) four different HLA class II molecules (HLA-DR, DRw52, DQ, and DP) was studied in 15 patients with active juvenile chronic arthritis (JCA), 10 patients with JCA in remission, and 11 age matched, healthy controls. "
06/15/1998 - "The role of the T-cell activation antigen CD26 was evaluated in viral entry and infection of CD4(+)/CXCR4(+) cells by the lymphotropic HIV-1 Lai isolate. "
09/01/1995 - "Experiments to identify cell determinants involved in HIV-1 tropism revealed a specific decrease in the expression of the T-cell activation antigen CD26 after monocytotropic (M-tropic) but not T-cell line-tropic (T-tropic) virus infection of the PM1 T-cell line. "
11/01/1996 - "Using these hybrids it is demonstrated that expression of CD4 and CD26, the T cell activation antigen dipeptidyl peptidase IV recently proposed as a CD4 cofactor necessary for HIV-1 infection, are not sufficient for HIV-1 entry. "
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
03/01/2007 - "Because antigen presenting is necessary for T-cell activation, antigen-presenting cells should be involved in the pathogenesis of psoriasis. "
01/01/1991 - "Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis."
|4.||Graft vs Host Disease (Graft-Versus-Host Disease)
06/15/1997 - "Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease."
05/01/1999 - "Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation."
08/01/1996 - "Expression of the activation antigen CD27 in rheumatoid arthritis."
09/01/1989 - "The expression of a new activation antigen, T cell lineage specific activation antigen (TLiSA1) on peripheral blood T cells from 16 rheumatoid arthritis (RA) and 8 systemic lupus erythematosus (SLE) patients and synovial fluid T cells from RA patients was determined in the context of T cell activation. "
|2.||Interleukin-2 Receptors (IL 2 Receptor)
|3.||HLA-DR Antigens (HLA-DR)
|5.||Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
|10.||Interleukin-4 (Interleukin 4)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)